Back

Novel risk model for predicting acute adverse drug reactions following cardiac catheterization from TRUST study (the safety and tolerability of ultravist in patients undergoing cardiac catheterization

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation 2 Prevention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Yong Liu

Guangdong General Hospital Guangdong Cardiovascular Institute, Guangzhou (China)

9 More presentations in this session

Presentation thumbnail
Network meta-analysis comparing iFR vs. FFR vs. coronary angiography to drive coronary revascularization
Doctor F. Fioravanti (Milan, IT)
Abstract
Presentation thumbnail
Chronic total occlusion represents an independent predictor for mortality in malignant arrhythmias and sudden cardiac death
Doctor I. El-Battrawy (Bochum, DE)
Abstract
Presentation thumbnail
Evaluation of safety and efficacy of sirolimus eluating coronary stent yukon choice flex in all comer coronary artery disease patients a single center experience
Doctor S. Kasturi (Hyderabad, IN)
Abstract Slides
Presentation thumbnail
Calcifications as an indicator for an NIRS-based risk profile of coronary atherosclerotic plaques.
Ms E. Hartman (Rotterdam, NL)
Abstract
Presentation thumbnail
Referral of patients for fractional flow reserve using quantitative flow ratio
Mr J. Smit (Leiden, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation 2

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources